2001
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
Celentano D, Galai N, Sethi A, Shah N, Strathdee S, Vlahov D, Gallant J. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001, 15: 1707-1715. PMID: 11546947, DOI: 10.1097/00002030-200109070-00015.Peer-Reviewed Original ResearchConceptsInjection drug usersActive antiretroviral therapyAntiretroviral therapyDrug usersCell countLow health care accessNon-HAART regimensAntiretroviral therapy useDual combination therapyProportional hazards regressionMain outcome measuresMore treatment optionsHealth care accessNon-drug usersHAART regimenLow CD4HAART useHIV careCohort studyStudy clinicTherapy useSelf-reported initiationHazards regressionMethadone treatmentTreatment eligibility
1995
Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md
Nelson K, Vlahov D, Solomon L, Cohn S, Muñoz A. Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md. JAMA Internal Medicine 1995, 155: 1305-1311. PMID: 7778962, DOI: 10.1001/archinte.1995.00430120091011.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionHuman immunodeficiency virusDrug usersVirus infectionImmunodeficiency virusEffective human immunodeficiency virus (HIV) vaccineHuman immunodeficiency virus risk factorsIncident human immunodeficiency virus (HIV) infectionsHuman immunodeficiency virus (HIV) seroconversionHuman immunodeficiency virus (HIV) antibodyHuman immunodeficiency virus (HIV) vaccinesIllicit drug injectionInjecting Drug UsersHigh-risk populationImmunodeficiency virus vaccinesIncidence of infectionPrevention of infectionSterile injection equipmentEnzyme-linked immunosorbent assaySeronegative participantsStudy clinicAnnual incidenceImmunodeficiency syndromeOverall incidence
1991
Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users
Nelson K, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony J. Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users. JAMA 1991, 266: 2259-2261. PMID: 1920726, DOI: 10.1001/jama.1991.03470160091038.Peer-Reviewed Original ResearchConceptsHistory of diabetesIntravenous drug usersDrug usersHIV seroprevalenceDrug useHuman immunodeficiency virus (HIV) seroprevalenceHuman immunodeficiency virus (HIV) infectionLow HIV seroprevalenceImmunodeficiency virus infectionSafe injection practicesApparent protective effectSterile injection equipmentCross-sectional surveyHIV infectionStudy clinicInjection paraphernaliaVirus seroprevalenceVirus infectionDrug treatmentProtective effectInjection practicesDiabetesPast monthSeroprevalenceSimilar duration